iifl-logo

Q-Line Biotech Ltd Share Price Live

Add as a Preferred Source on Google
546.5
(-5.15%)
Jun 25, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

No Chart Data Available

  • Open570
  • Day's High575
  • 52 Wk High600
  • Prev. Close576.2
  • Day's Low538
  • 52 Wk Low 431
  • Turnover (lac)1,173.88
  • P/E0
  • Face Value10
  • Book Value0
  • EPS0
  • Mkt. Cap (Cr.)1,274.89
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Q-Line Biotech Ltd KEY RATIOS

Sector

Trading

Open

₹570

Prev. Close

₹576.2

Turnover(Lac.)

₹1,173.88

Day's High

₹575

Day's Low

₹538

52 Week's High

₹600

52 Week's Low

₹431

Book Value

₹0

Face Value

₹10

Mkt Cap (₹ Cr.)

1,274.89

P/E

0

EPS

0

Divi. Yield

0

Q-Line Biotech Ltd Corporate Action

12 Jun 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Q-Line Biotech Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Q-Line Biotech Ltd SHAREHOLDING SNAPSHOT

28 Jun, 2026|02:51 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 92.24%

Foreign: 0.00%

Indian: 92.24%

Non-Promoter- 7.75%

Institutions: 7.75%

Non-Institutions: 0.00%

Custodian: 0.00%

Share PriceShare Price

Q-Line Biotech Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

No Record Found

No Record Found

No Record Found

No Record Found

Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023

Gross Sales

341.74

313.14

203.65

182.74

Excise Duty

0

0

0

0

Net Sales

341.74

313.14

203.65

182.74

Other Operating Income

0

0

0

0

Other Income

5.7

8.83

2.8

2.08

Q-Line Biotech Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,038

343.33,95,240.96343.560.046,810.08482.58

Premier Energies Ltd

PREMIERENE

1,050.6

333.2447,651.2951.970.02275.1742.62

Aegis Logistics Ltd

AEGISLOG

1,140.65

42.4340,029.8524.310.761,713.1698.55

Redington Ltd

REDINGTON

286.4

1822,386.11288.552.119,587.4467.83

Honasa Consumer Ltd

HONASA

417.7

69.9713,618.0364.470.72607.6542.84

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Q-Line Biotech Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Saurabh Garg

Whole Time Director

Kuldeep Chowdhry

Whole-time Director

Ajay Kumar Mahanty

Whole-time Director

Yethadka Subraya Prabhakara

Non Executive Director

Abhay Agrawal

Non Executive Director

Amita Garg

Non Executive Director

Ayush Garg

Independent Director

Abhishek Mishra

Independent Director

Pravir Kumar

Independent Director

ROHIT NANDAN

Independent Director

Jai Prakash Singh

Company Secretary / Compliance Officer

Akhand Pratap Singh.

Registered Office

298-281 Transport Nagar Kanpur,

#NAME?,

Uttar Pradesh - 226012

Tel: +91 522 2435 570

Website: http://www.qlinebiotech.com

Email: compliance@qlinebiotech.com

Registrar Office

9 ShivShakti Indl Es,

J R Boricha Marg, Lower Parel,

Mumbai - 400 011

Tel: 022- 23016761 / 2301

Website: www.purvashare.com

Email: support@purvashare.com

Summary

Q-Line Biotech Limited was originally incorporated as POCT Services Private Limited on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Compa...
Read More

Company FAQs

What is the Q-Line Biotech Ltd share price today?

The Q-Line Biotech Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹546.5 today.

What is the Market Cap of Q-Line Biotech Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Q-Line Biotech Ltd is ₹1274.89 Cr. as of 25 Jun ‘26

What is the PE and PB ratio of Q-Line Biotech Ltd?

The PE and PB ratios of Q-Line Biotech Ltd is 0 and 5.22 as of 25 Jun ‘26

What is the 52 Week High and Low of Q-Line Biotech Ltd?

The 52-week high/low is the highest and lowest price at which a Q-Line Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Q-Line Biotech Ltd is ₹431 and ₹600 as of 25 Jun ‘26

What is the CAGR of Q-Line Biotech Ltd?

Q-Line Biotech Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at N/I%, 3 Month at N/I% and 1 Month at 15.15%.

What is the shareholding pattern of Q-Line Biotech Ltd?

The shareholding pattern of Q-Line Biotech Ltd is as follows:
Promoters - 67.51 %
Institutions - 11.81 %
Public - 20.67 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.